Distribution group Bunzl (LSE:BNZL) has acquired the whole of Blueleaf Care, a UK supplier of products to care and nursing homes that generated Revenue of £58m in 2025. The company has not disclosed the price paid or other financial terms.

What was announced

Bunzl plc (LSE:BNZL), the FTSE 100 distribution and services group, announced on 8 October 2026 that it has acquired 100% of Blueleaf Care (Blueleaf). The announcement describes the transaction as an Acquisition that has taken place, rather than an agreement subject to future completion, although it does not give a specific completion date.

Blueleaf is a UK-based distributor of care and nursing home products. According to Bunzl, its range covers consumables, cleaning solutions, continence care, equipment, furniture and personal protective equipment (PPE). The Business mainly serves care homes. Blueleaf generated revenue of £58m in 2025.

Deal terms and what was not disclosed

The announcement is brief and leaves several financial details undisclosed. Bunzl has not published the consideration paid, how the acquisition was funded, or the multiple of revenue or Earnings implied by the price. It has also not disclosed Blueleaf's profitability, margins, headcount, number of customers or sites, or any expected contribution to Bunzl's own earnings. No timetable for integration was given, and the statement does not say whether any deferred or contingent consideration is involved.

Because these details are absent, the size of the deal relative to Bunzl's wider group cannot be assessed from the announcement itself. The only quantitative information provided is Blueleaf's 2025 revenue of £58m. Investors seeking further detail may need to wait for Bunzl's next scheduled update, where the company may report on acquisition activity, although the announcement does not commit to this.

Strategic rationale

Bunzl said Blueleaf is highly complementary to its existing business. The group expects the acquisition to strengthen its position in the UK care home market, broaden the range it can offer customers, and allow Blueleaf to draw on Bunzl's scale and capabilities. The statement presents the deal as a bolt-on that adds both product breadth and customer relationships in a specific end market, rather than as an entry into a new sector.

Chief executive Frank van Zanten said he was delighted to welcome the Blueleaf team to Bunzl. He described Blueleaf as a high-quality business that further strengthens Bunzl's position in what he called the attractive UK care home market, and said the group looks forward to supporting Blueleaf in its next phase of growth.

The product categories listed, ranging from everyday consumables such as continence and cleaning products to larger items such as equipment and furniture, indicate that Blueleaf acts as a broad supplier to its care home customers rather than a single-category specialist. The announcement does not say whether Blueleaf will retain its Brand or be combined with an existing Bunzl operation, nor whether its management team will remain in place, although the chief executive's reference to welcoming the Blueleaf team suggests the business joins the group with its staff.

What to watch next

The main open questions concern the undisclosed financial terms and how Blueleaf will be reported within the group. Points to monitor include whether Bunzl discloses the consideration or the expected earnings contribution in future trading statements or results, how Blueleaf is integrated with Bunzl's existing UK healthcare-related activities, and whether the company provides any update on performance in the care home market.

Bunzl named Frank van Zanten, chief financial officer Richard Howes and Anjali Kotak, head of Investor relations and communications, as contacts, with Teneo handling media enquiries. The announcement contained no forward guidance on Blueleaf's revenue or profit beyond the 2025 revenue figure.